Skip to Main Content

Paper Details

HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.
Cell Rep
5
2023
B cells, HIV, HIV-1, envelope trimer, humans, tier-
Author NameAffiliation
Baoshan ZhangVaccine Research Center, National Institutes of Health
Chen-Hsiang ShenVaccine Research Center, National Institutes of Health
Cheng ChengVaccine Research Center, National Institutes of Health
Sijy O'DellVaccine Research Center, National Institutes of Health
Reda RawiVaccine Research Center, National Institutes of Health
Yaroslav TsybovskyFrederick National Laboratory for Cancer Research
Tongqing ZhouVaccine Research Center, National Institutes of Health
Nicole A Doria-RoseVaccine Research Center, National Institutes of Health
Lawrence ShapiroZuckerman Mind Brain Behavior Institute, Columbia University, Columbia University Vagelos College of Physicians and Surgeons
Lawrence ShapiroZuckerman Mind Brain Behavior Institute, Columbia University, Columbia University Vagelos College of Physicians and Surgeons
Adrian B McDermottVaccine Research Center, National Institutes of Health
Peter D KwongVaccine Research Center, National Institutes of Health, Columbia University Vagelos College of Physicians and Surgeons
  • 1 - 12

Datasets

Release 1.2